Our international team consists of highly enthusiastic professionals, trained in microbiology, molecular biology, and drug discovery. This provides the foundation for cutting-edge research and innovative solutions. We pride ourselves on delivering high quality products and services.
Koen Dechering, PhD
Chief Executive Officer
Dr. Dechering is a molecular pharmacologist with a background in pharmaceutical and academic research management. He worked as a director of research at Merck Sharpe & Dohme and as assistant professor at the Radboud University in Nijmegen, The Netherlands.
Prof. Dr. Robert Sauerwein, PhD, MD
Chief Scientific Officer
Dr. Sauerwein is an internationally renowned scientist in the field of malaria transmission with an extensive track record in basic and clinical research. He is head of the Centre for Clinical Malaria Studies (CCMS) in Nijmegen, The Netherlands and full Professor of Medical Parasitology at the Radboud University Medical Center.
Maes van Lanschot, LLM
Chief Financial Officer
Mr. van Lanschot has over 20 years worth of experience in the financial industry, including corporate banking, treasury, debt restructuring and asset management working at ABN- AMRO and ING. He was Chief Investment Officer and member of the Board of ING IM Europe.
Karin Koolen, BSc
Mrs. Koolen has a broad knowledge of molecular and cellular biology and assay development. She previously worked at the Radboud University Nijmegen Medical Centre in the Netherlands.
Judith Bolscher, MSc
Assistant Research Manager
Mrs. Bolscher has ample experience in immunology and cellular biology and has previously worked in academic and industrial research environments in the Netherlands and in the US.
Martijn Vos, MSc
Mr. Vos is an expert in molecular biology and parasite transgenesis. He has a broad experience in Medical Parasitology and has previously worked at the Radboud University Nijmegen Medical Centre in the Netherlands.
Angelika Sturm, PhD
Dr. Sturm is a molecular biologist with a broad expertise in malaria life cycle studies and entomology. She started her career in Germany and has continued her research in Australia before joining TropIQ.
Rob Henderson, BSc
Mr. Henderson is a skilled molecular biologist with previous experience in parasite epigenetics at the department of Molecular Biology, Radboud University Nijmegen.
Mrs. Pelser-Posthumus is an expert in experimental handling of mosquitoes and serves both TropIQ and the mosquito unit of the Radboud University Nijmegen Medical Centre.
Mrs. Bosman is a highly experienced tissue culture technician with a strong quality control background. She has previously worked as a laboratory technician at MSD.
Deeya Shankari Rajagopal
Ms. Shankari Rajagopal is a master student from the HAN University of Applied Sciences and will be with us for two years.
Dr. Patel has a background in virology and worked at Cambridge University before earning her PhD from the University of Zurich. She is leading the new virology effort of TropIQ in collaboration with Protinhi Therapeutics.
Tonnie Huijs, BSc
Mr. Huijs has previously worked at the Radboud Medical Centre specialising in tissue engineering. He has a broad experience in tissue culture and assay development.
Rianne van der Laak, BSc
Ms. van der Laak has previously worked in a variety of companies which allowed her to gain a broad range of cell biology, molecular biology and microbiology skills.
Marnix Vlot, PhD
Dr. Vlot has earned his PhD in molecular microbiology at Wageningen University. He specialises in the molecular mechanism of the CRISPR-Cas gene editing system and will apply his skills to our malaria drug discovery program.
Youri van Nuland, PhD
Dr. van Nuland is an experienced biochemist with a PhD from Wageningen University in the Netherlands. He is an expert in industrial biotechnology and previously worked on metabolic engineering of microorganisms at the interface of public-private research.
Mr. Seijger is an undergraduate student at the Saxion University of Applied Sciences in Enschede. He will be doing an internship contributing to projects involving malaria transmission. He will stay with us until July 2019.